113 related articles for article (PubMed ID: 36059144)
1. Does SARS-CoV2 vaccine exposure trigger acute-onset polyradiculopathy characterized by more common facial paralysis?
Galassi G; Kaleci S
Muscle Nerve; 2022 Nov; 66(5):E30-E31. PubMed ID: 36059144
[No Abstract] [Full Text] [Related]
2. Only blame SARS-CoV-2 vaccination for facial palsy after alternative etiologies have been ruled out.
Finsterer J; Scorza FA
Therapie; 2023; 78(4):463-464. PubMed ID: 37268504
[No Abstract] [Full Text] [Related]
3. Adenovirus COVID-19 Vaccines and Guillain-Barré Syndrome with Facial Paralysis.
Pegat A; Vogrig A; Khouri C; Masmoudi K; Vial T; Bernard E
Ann Neurol; 2022 Jan; 91(1):162-163. PubMed ID: 34699065
[No Abstract] [Full Text] [Related]
4. Reply to 'Adenovirus COVID-19 Vaccines and Guillain-Barré Syndrome with Facial Paralysis' by Dr Pegat et al.
Maramattom BV
Ann Neurol; 2022 Jan; 91(1):163. PubMed ID: 34704270
[No Abstract] [Full Text] [Related]
5. Clinical Variant of Guillain-Barre Syndrome With Prominent Facial Diplegia After AstraZeneca Coronavirus Disease 2019 Vaccine.
Badoiu A; Moranne O; Coudray S; Ion IM
J Clin Neuromuscul Dis; 2021 Dec; 23(2):115-116. PubMed ID: 34808658
[No Abstract] [Full Text] [Related]
6. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
Li X; Raventós B; Roel E; Pistillo A; Martinez-Hernandez E; Delmestri A; Reyes C; Strauss V; Prieto-Alhambra D; Burn E; Duarte-Salles T
BMJ; 2022 Mar; 376():e068373. PubMed ID: 35296468
[TBL] [Abstract][Full Text] [Related]
7. A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine.
Nasuelli NA; De Marchi F; Cecchin M; De Paoli I; Onorato S; Pettinaroli R; Savoini G; Godi L
Neurol Sci; 2021 Nov; 42(11):4747-4749. PubMed ID: 34272622
[TBL] [Abstract][Full Text] [Related]
8. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination.
Dang YL; Bryson A
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848426
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Guillain-Barré syndrome following SARS-CoV-2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines.
García-Grimshaw M; Galnares-Olalde JA; Bello-Chavolla OY; Michel-Chávez A; Cadena-Fernández A; Briseño-Godínez ME; Antonio-Villa NE; Núñez I; Gutiérrez-Romero A; Hernández-Vanegas L; Del Mar Saniger-Alba M; Carrillo-Mezo R; Ceballos-Liceaga SE; Carbajal-Sandoval G; Flores-Silva FD; Díaz-Ortega JL; Cortes-Alcalá R; Pérez-Padilla JR; López-Gatell H; Chiquete E; Reyes-Terán G; Arauz A; Valdés-Ferrer SI
Eur J Neurol; 2022 Nov; 29(11):3368-3379. PubMed ID: 35841212
[TBL] [Abstract][Full Text] [Related]
10. Guillain-Barre syndrome should be monitored upon mass vaccination against SARS-CoV-2.
Leung C
Hum Vaccin Immunother; 2021 Sep; 17(9):2957-2958. PubMed ID: 34032555
[TBL] [Abstract][Full Text] [Related]
11. Acute-onset polyradiculoneuropathy after SARS-CoV2 vaccine in the West and North Midlands, United Kingdom.
Loo LK; Salim O; Liang D; Goel A; Sumangala S; Gowda AS; Davies B; Rajabally YA
Muscle Nerve; 2022 Feb; 65(2):233-237. PubMed ID: 34786740
[TBL] [Abstract][Full Text] [Related]
12. [Isolated facial diplegia as an atypical variant of Guillain-Barre syndrome after suspected SARS-CoV-2 infection].
Lavilla Olleros C; López-Rubio M; Fanciulli C; González-Munera A; Millán Núñez-Cortés J
Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):405-407. PubMed ID: 34962738
[TBL] [Abstract][Full Text] [Related]
13. [Facial diplegia due to Guillain-Barre syndrome].
RISER M; GERAUD J; BENAZET J; MIMART J; KARKOUS E
Rev Otoneuroophtalmol; 1959; 31():355-6. PubMed ID: 14437557
[No Abstract] [Full Text] [Related]
14. Guillain-Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barré syndrome.
Ling L; Bagshaw SM; Villeneuve PM
CMAJ; 2021 Nov; 193(46):E1766-E1769. PubMed ID: 34810163
[No Abstract] [Full Text] [Related]
15. [ZOSTER POLYRADICULONEURITIS WITH MANIFESTATIONS OF LANDRY'S PARALYSIS].
NEVSIMAL O; LEHOVSKY M
Cesk Neurol; 1963 Jul; 26():280-3. PubMed ID: 14042823
[No Abstract] [Full Text] [Related]
16. Guillain-Barré Syndrome Associated with COVID-19 Vaccination.
Finsterer J; Scorza FA; Scorza CA
Emerg Infect Dis; 2022 May; 28(5):1079-1080. PubMed ID: 35447058
[No Abstract] [Full Text] [Related]
17. Reply to the spectrum of SARS-CoV-2 associated polyradiculitis is broad.
Wang Y; Wang Y; Li X; Wang H
QJM; 2022 Jan; 114(11):836-837. PubMed ID: 34191014
[No Abstract] [Full Text] [Related]
18. Guillain-Barre Syndrome, Facial Diplegia, and Pfizer COVID-19 Vaccine.
J Emerg Med; 2022 Mar; 62(3):426. PubMed ID: 35065856
[No Abstract] [Full Text] [Related]
19. Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report.
Masuccio FG; Comi C; Solaro C
Acta Neurol Belg; 2022 Oct; 122(5):1369-1371. PubMed ID: 34767184
[No Abstract] [Full Text] [Related]
20. Association of Facial Paralysis With mRNA COVID-19 Vaccines: A Disproportionality Analysis Using the World Health Organization Pharmacovigilance Database.
Renoud L; Khouri C; Revol B; Lepelley M; Perez J; Roustit M; Cracowski JL
JAMA Intern Med; 2021 Sep; 181(9):1243-1245. PubMed ID: 33904857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
